Bath & Body Works reported fourth-quarter earnings that surpassed analyst estimates, driven by robust same-store sales growth and effective inventory management. The stock rose following the release, reflecting investor confidence in the retailer's ongoing recovery.
- BBWI Q4 adjusted EPS: $1.48 vs. $1.42 expected
- Q4 revenue: $1.24 billion, up 5.7% YoY
- Same-store sales growth: 7.2%
- Gross margin improved to 59.3%
- BBWI shares rose 6.3% post-earnings
- Full-year 2025 net income: $412 million
Bath & Body Works posted adjusted earnings per share of $1.48 for the fourth quarter of fiscal 2025, topping the consensus estimate of $1.42. Revenue reached $1.24 billion, a 5.7% year-over-year increase, fueled by a 7.2% rise in same-store sales and strong performance in its fragrance and skincare product lines. The company attributed the results to improved supply chain execution and higher consumer demand during the holiday season. The performance underscores a continued rebound in consumer spending within the personal care and fragrance segment, a key component of the consumer discretionary sector. Despite macroeconomic headwinds, Bath & Body Works maintained disciplined cost controls, achieving a gross margin of 59.3%, up from 58.1% in the prior-year quarter, reflecting improved operational efficiency. Shares of BBWI gained 6.3% in after-hours trading, signaling positive market reception. The stock’s move comes amid broader retail sector momentum, with the XLY ETF, which tracks consumer discretionary firms, also seeing modest gains. Meanwhile, the broader market remained flat, indicating the rally was company-specific rather than sector-wide. The results follow a strong fiscal year, with full-year revenue of $4.91 billion and net income of $412 million. Management reaffirmed its outlook for fiscal 2026, projecting low single-digit revenue growth and continued margin expansion through digital initiatives and store optimization.